View Article

Abstract

Background-Molecular docking serves as an effective method for exploring the molecular targets of nutraceuticals in the treatment of diseases. Objectives-This review focuses on understanding the basics, types, approaches, applications, advantages and disadvantages of docking. Discussion-The basics of docking involve study of the ligands and proteins. The types of docking encompass Rigid Docking, Flexible-Rigid Docking and Flexible Docking. The approaches include determination of the energy profile for the docked conformer of the ligand target and determination of the complementarity of surfaces between the ligand and the target. Applications discussed in this review are Hit identification, Lead optimization, Bioremediation, Remediation, Binding site prediction, Protein – protein/ nucleic acid interactions, Searching for lead structures for protein targets, Mechanisms of enzymatic reactions, Protein engineering, Molecular dynamics simulation and Structure elucidation. The advantages of docking like easy understanding of the mechanism of action and disadvantages of docking like everchanging dynamic nature of protein-ligand interactions making it difficult to ascertain the conformational stabilities are also explained in this article. Conclusion-Docking study can include the preferred orientation of a molecule when bound to another molecule. This information can be used to predict the strength of the association between the two molecules.

Keywords

Docking, Ligands, Proteins, Nutraceuticals and Protein-Ligand interactions.

Introduction

What is docking?

Docking is a molecular modelling method (using a computer software) aimed at discovering the optimal fit between a ligand (Drug) and its binding site (receptor or protein) 1. Usually, a favorable binding or interaction with the receptor or protein initiates a positive response which is seen as cure of disease or its symptoms2.

Basics of Docking

Protein

Proteins are large, complex molecules that are essential to numerous bodily functions. They perform the majority of the work in cells and are necessary for the organs and tissues of the body to be regulated, functional, and structural.1 Although they can be depicted as primary, secondary, tertiary, and even quaternary structures, only the primary (amino acid) sequence is significant from a nutritional perspective. Similarly, while many substances in the body can be chemically classified as amino acids, we are only interested in the 20 canonical amino acids that are encoded in dna and the five others that have quantitatively significant functions in the body: taurine, ornithine, citrulline, γ-aminobutyrate, and β-alanine. 2 Since the body cannot generate their carbon skeletons, nine of the twenty amino acids found in proteins are regarded as nutritionally indispensable (essential) in adult humans. Leucine, valine, isoleucine, histidine, lysine, methionine, threonine, tryptophan, and phenylalanine are the nine amino acids in question. Moreover, two more are produced from their essential precursors: tyrosine from phenylalanine and cysteine from methionine. 2

Ligand

Ligands are neutral molecules or ions that form a connection with a central metal ion or atom. The core atom functions as a Lewis acid, which accepts electron pairs, while ligands function as Lewis bases, which give electron pairs. To establish covalent connections with the centre atom, ligands need at least one donor atom with an electron pair. 3 A ligand's structure and/or activity are changed when it interacts to its specific receptor, triggering a variety of biological reactions. In all multicellular animals, these cellular reactions are essential for cell motility, proliferation, survival, and differentiation.3 Ligands can be neutral molecules, cations, or anions. Ligands can be further categorized into tridentate, bidentate, and monodentate, among others. 4

Monodentate Ligands

The literal meaning of "monodentate" is "one tooth," signifying that the ligand binds to the centre via a single atom. Monodentate ligands include, for instance, hydroxide ions (called hydroxo when a ligand is present), ammonia (called ammine when a ligand is present), water (called aqua when a ligand is present), and chloride ions (called chloro when a ligand is present). 4

Bidentate Ligands

Bidentate ligands can attach to a central metal atom or ion at two different locations since they have two donor atoms. The oxalate ion (OX) and ethylenediamine (EN) are typical examples of bidentate ligands. The nitrogen (blue) atoms on the margins of the ethylenediamine diagram below each contain two free electrons that can be used to form a bond with a central metal atom or ion. 4

Polydentate Ligands

A central metal atom or ion can be bonded to by a variety of atoms in polydentate ligands. One type of polydentate ligand is EDTA, a hexadentate ligand, which contains six donor atoms with electron pairs that can form a connection with a central metal atom or ion.4 One well-known in silico structure-based technique that is frequently applied in drug development is molecular docking. Without knowing the chemical structure of other target modulators beforehand, docking makes it possible to identify new compounds of therapeutic relevance, anticipate ligand-target interactions at the molecular level, or define structure-activity correlations (sar). Docking's functions and applications in drug development have altered significantly over the past few years, despite the fact that it was initially created to aid in understanding the mechanics of molecular recognition between tiny and large molecules.5 Numerous molecular modeling techniques have been effectively integrated into pharmaceutical research to investigate intricate biological and chemical systems in a range of drug discovery initiatives. It has been very beneficial to identify and create new, promising chemicals by combining theoretical and experimental approaches. Modern drug design makes extensive use of molecular docking techniques to investigate the ligand conformations that are adopted within the binding sites of macromolecular targets. By assessing important occurrences in the intermolecular recognition process, this method also calculates the ligand-receptor binding free energy. Since there are many different docking algorithms available today, it is crucial to comprehend the benefits and drawbacks of each approach in order to create methods that work and produce outcomes that are pertinent.6 Molecular docking fundamentals in order to predict a small molecule's affinity and activity, docking is frequently utilized to predict how therapeutic small molecules would fit with their protein targets. 7 Docking is essential to logical medication design. The biological and pharmacological significance of docking investigations has led to a lot of work to enhance docking prediction systems. By using a mathematical technique called docking, one can predict the orientation a molecule will prefer when joined to form a stable complex. 7 Based on their preferred position, scoring functions can be used to determine the strength of the bond or binding affinity between two molecules. 7 Docking methodology is currently used as a standard computational tool in drug design for lead compound optimization and in virtual screening studies to find novel biologically active molecules. Its goal is to predict the experimental binding modes and affinities of small molecules within the binding site of specific receptor targets.8 Over the past few decades, many software programs have been created; some well-known examples include autodock, autodock vina, dockthor, gold, flexx, and molegro virtual docker.9

Types Of Docking

Based on the flexibility of the interacting molecules, receptor, and ligand, there are three types of docking studies: rigid docking, flexible-rigid docking, and flexible docking. 10 Flexible docking produces more accurate and dependable results because molecules' relative bond length and angle can change. 10 Receptor and ligand molecules are both regarded as rigid bodies in rigid type docking. Because of their unaltered shape, each molecule's internal geometry remains constant. Only the translational and rotational degrees of freedom are taken into consideration because of its positional flexibility. The results of this early docking technique, which can be performed between macromolecules like two protein molecules, are less accurate and dependable, which is why it is not as commonly used in modern docking studies. 10 This approach allows for the application of the lock-and-key principle. Both ligand and receptor molecules are regarded as rigid bodies in rigid type docking. Since their shape remains constant, each molecule's internal geometry remains unchanged. Since its position is changeable, only the translational and rotational degrees of freedom are taken into account.10

Rigid Docking

Both ligand and receptor molecules are regarded as rigid bodies in rigid type docking. Since their shape remains constant, each molecule's internal geometry remains unchanged. Since its position is changeable, only the translational and rotational degrees of freedom are considered. Since the results of this early docking method—which can be performed between macromolecules like two protein molecules—are less precise and dependable, it is not as commonly used in modern docking studies. This approach allows for the application of the lock-and-key principle. 10

Flexible-Rigid Docking

This docking technique is semi-flexible. Either the ligand or the receptor is viewed as a rigid body in this situation. Typically, the ligand's conformation varies while the receptor's shape remains constant. This approach is widely used because it produces more accurate and dependable results than the rigid docking method. 10

Flexible Docking

It is a completely flexible docking method where both the ligand and the receptor are regarded as flexible bodies. In other words, the rotations of the molecules—both the ligand and the receptor—are counted to find the best possible conformation and orientation for their interactions. By altering the rotatable bonds and torsion angles, the molecule's shape can be changed. This approach produces a highly accurate docked conformation prediction that most likely matches experimental findings, but it may take a lot of time and computational effort.10

Approaches Of Docking

There are two main methods for carrying out molecular docking. One method uses computer simulations to determine energy profile for the docked conformer of the ligand target. In contrast, the second strategy makes use of a method that determines the complementarity of surfaces between the ligand and the target.11Protein structure preparation is the first stage in molecular docking; the most popular method is to just eliminate all solvent molecules,ions,and other tiny molecular ligands, leaving a completely vacant binding pocket for docking.Although this method is straightforward to operate, it results in a difference between the pocket conditions for docking and physiological conditions. 12 On the one hand, certain water molecules may provide extremely potent hydrogen bonding interactions, that facilitate protein-ligand binding. These interactions are challenging to replace, as doing so could result in a false-positive docking result.12

Different Types of Interactions

Interaction forces are generally separated into four classes:

(1) electrostatic forces - dipole-dipole, charge-dipole and charge-charge.

(2) electrodynamics forces- van der waals interaction.

(3) steric forces - caused by entropy.

(4) solvent-related forces - hydrogen bond and hydrophobic interactions.13

Application Of Molecular Docking

While ligand binding can result in agonism or antagonism, molecular docking interactions     can either activate or inhibit the protein. Perhaps using molecular docking to:

  1. Hit identification (virtual screening)
  2. Lead optimization (drug discovery)
  3. Bioremediation
  4. Remediation
  5. Binding site prediction (blind docking)
  6. Protein – protein/ nucleic acid interactions
  7. Searching for lead structures for protein targets
  8. Mechanisms of enzymatic reactions
  9. Protein engineering
  10. Molecular dynamics simulation
  11. Structure elucidation13

Hit Identification (Virtual Screening)

A successful drug discovery initiative starts with hit identification. The proper tiny molecules, often known as hits, that attach to the target and alter its function are found during this procedure. High-quality initial hits accelerate drug discovery projects and reduce attrition rates.  In order to select the most promising hit series for the start of the hit-to-lead (h2l) process, a number of orthogonal approaches, including biophysical assays, are used for hit qualification and characterisation after a hit discovery campaign discovered multiple hit series.14 Virtual screening is the process of predicting which chemicals in a big library are most likely to bind to a target protein using computer methods like molecular docking and molecular dynamics simulations. 15

Lead Optimization (Drug Discovery)

The process of developing and enhancing a pre-identified lead compound is known as "lead optimization." it entails modifying various aspects of the molecule through chemical changes. Synthetic modifications are made throughout this procedure to maximize the compound's activity, potency, and selectivity as well as its ADMET characteristics (absorption, distribution, metabolism, excretion, and toxicity). 16

These ADMET characteristics include the compound's ability to enter the bloodstream (absorption), move throughout the body to its intended location (distribution), break down once inside the body (metabolism), expel the compound and any metabolites from the body (excretion), and have any adverse effects on the body (toxicity). Nevertheless, these characteristics are tracked throughout the earlier phases of drug development and are not just taken into account during the lead optimization phase.16

Remediation

Protein-ligand docking can be used to predict which pollutants are enzyme-degradable. The most efficient medication may be collected using it, as well as the intended location. 7 it is possible to identify enzymes and their mechanisms of action by molecular docking. It can also be used to ascertain the connections between proteins. Virtual screening of molecules is done using the remediation.17

Binding Site Prediction (Blind Docking)

Understanding the precise sequence areas that mediate contact, or binding sites, is essential to comprehending biological processes. Due to experimental limitations, computational approaches frequently require data that is not available at the proteome-scale, while experimental methods frequently report erroneous binding sites.18 When targeting places other than the initial substrate binding site, this technique is also crucial. One of the crucial objectives in drug discovery is identifying the allosteric binding site that regulates the target protein's activity.19

Protein – Protein/ Nucleic Acid Interactions

The movement of genetic information between DNA, RNA, and protein is negotiated by an astounding variety of protein–nucleic acid interactions. The range of gene expression is covered by the reviews in this section of current opinion in structural biology, including DNA packaging, unwinding and repair, RNA synthesis mechanisms and regulation, post-transcriptional modification, protein synthesis initiation, and targeting of emerging polypeptides for secretion or membrane insertion.20

Searching For Lead Structures for Protein Targets

The lead structure is where the hunt for a novel medication begins. Although such a chemical already has a desirable biological effect, certain qualities are still insufficient for its therapeutic application. The phrase "lead structure" also refers to the ability to create analogues by specific chemical modifications that result in analogues that are superior to the lead structure in terms of, say, potency or selectivity. Optimizing every feature until a finished product is prepared for therapeutic use is the aim.21

Protein Engineering

Protein engineering is the design of new enzymes or proteins with new or desirable functions. It is based on the use of recombinant DNA technology to change amino acid sequences. 22

Mechanisms Of Enzymatic Reactions

Quantum mechanical, classical mechanical, and statistical mechanical methods have been combined with site-directed mutagenesis, protein structure determination, and fast computers and algorithms to conduct enzymatic operations.23

Bioremediation

Molecular docking is used in bioremediation to predict the binding affinity of small molecules to enzymes involved in the degradation of environmental pollutants. Docking can help in designing inhibitors or activators of these enzymes to enhance bioremediation efficiency. 24

Molecular Dynamics Simulation

Molecular docking can be combined with molecular dynamic simulations to study the dynamic behavior of protein–ligand complexes. The simulations can help in understanding the conformational changes that occur upon ligand binding and the stability of the complex48. Several software tools combine molecular docking and dynamics simulation. These include frequently used software like autodock, vina, glide, and gold. In addition to molecular docking, they provide capabilities for conducting molecular dynamics simulations, allowing for the exploration of protein–ligand interactions over time and the analysis of their dynamic behavior. 24

Structure Elucidation

Molecular docking can also be used to elucidate the structure of proteins with unknown structures. Docking can be used to predict the binding modes of small molecules to the protein and generate a homology model of the protein based on the binding mode prediction. The generated model can then be refined using experimental data to obtain an accurate structure of the protein.24

Docking Software

There are many dockings program in that the many freely available docking programs are available like,

  1. Dock
  2. Autodock
  3. Autodock vina
  4. Rdock
  5. Oedocking
  6. Swissdock
  7. Usef dock
  8. Igemdock
  9. Haddock
  10. Ledock
  11. Gold
  12. Glide
  13. Ligandfit molecular operating environment (MOE) dock
  14. Surflex-dock
  15. Flex
  16. Fred

Autodock/Vina

Autodock tools (ADT), a graphical user interface application, was used to finish intermediate processes including creating grid boxes and preparing protein and ligand pdbqt files. The protein was given polar hydrogens, fragmental volumes, solvation parameters, and unified atom Kollman charges via ADT. The prepared file was saved in pdbqt format by autodock. Using a grid box, autogrid was utilized to create the grid map. The grid centre was identified with dimensions (x, y, and z) of -1.095, -1.554, and 3.894. The grid size was set to 60 × 60 × 60 XYZ points with a grid spacing of 0.375 å. The ligand structure is used to compute a scoring grid in order to reduce computing time. The configuration file's grid box attributes and protein and ligand information were used to dock using autodock/vina. Autodock/vina uses a global optimizer for iterated local search. Both the protein and the ligands are regarded as stiff during the docking process. The result with the most advantageous free energy of binding was used to represent the results with a positional root-mean-square deviation (RMSD) of less than 1.0 å. For additional examination, the position with the lowest binding energy or affinity was taken out and matched with the receptor structure. 26

Gold (Genetic Optimization for Ligand Docking)

Gold studies the ligand conformational flexibility and the rotational flexibility of receptor hydrogens using genetic algorithms. Docking was carried out in gold using the wizard with the following default settings: select-pressure (1.1), number of operations (10,000), number of islands (1), niche size (2), population size (100), and operator weights for migrate (0), mutate (100), and crossover (100). Choosing a protein active site residue allowed for the definition of an active site with a 10 å radius sphere. By default, ten solutions were kept for each ligand, and all computations were performed using the genetic algorithm settings. A goldscore fitness function utilizes gold. Goldscore is a function that resembles a molecular mechanism and has been refined for determining ligand binding sites. 26

Flexx

Flexx, now a component of lead it, is a flexible docking technique that places ligands into the active site using an incremental construction (ic) algorithm and a pure empirical scoring system akin to the one created by Bohm and teammates. Each molecule is first broken up into a series of hard pieces based on rotatable bonds by ic algorithms, which then gradually put the pieces back together around the binding pocket. A ligands library was created and the ligands' pdb files were converted to a sybyl mol2 file format for docking research. Using the flexx graphic interface, a receptor description file was created. By choosing the protein's residue, an active site was established. Protein residues with a radius of around 10 å and centred on the ligand's centre of mass make up the active site. Every ligand in the data set had its best ten ranking poses chosen for additional investigation based on energy values. 26

Dock

One of the most well-known and established ligand-protein docking programs is dock.
Rigid ligands were employed in the first version; flexibility was subsequently added by gradually building the ligand inside the binding pocket. As previously stated, dock is a fragment-based approach that uses complimentary chemical and morphological techniques for generating potential ligand orientations. Although there are three distinct scoring functions that can be used to score these orientations, their serious use is limited because none of them include explicit hydrogen-bonding, solvation/desolvation, or hydrophobicity terms. While dock is helpful for quick docking and appears to manage apolar binding sites well, it is not the most precise program on the market.
25

Fred (Fast Rigid Exhaustive Docking)

The multi-conformer docking approach used by Fred creates a collection of low-energy conformers independently and then performs rigid docking for each conformer. Fred needed a ligand conformer library and a precisely generated receptor file in order to perform proper docking. While the ligand conformer library was made in omega 2.3.2 (open eye scientific software) with default parameters, the receptor file was constructed using the make-receptor file that was supplied in Fred. The receptor-centred docking box's volume was increased in all directions until it was roughly 31671 å3. The box's measurements were 28.10 å 32.91 å 34.25 å. A strong inhibitor against ASMT was obtained by docking ASMT with ligands conformer library using Fred with a gaussian type fitting score algorithm chemgauss4. The potentials between the chemically matching locations surrounding the ligand docked pose are used by chemgauss4. These chemical locations complement the receptor's adjacent specific groups. A favourable hydrogen bond score is achieved when a polar hydrogen site on one molecule overlaps a lone pair position on another molecule. Typically, the interactions are either hydrogen bond donors or acceptors. Steric, acceptor, donors, coordinating groups, metals, lone pairs, polar hydrogens, and chelator coordinating groups are among the interactions that can be scored using chemgauss functions. 26

ADVANTAGES

  • The use of docking in a specific drug delivery system is extremely beneficial. One can investigate the size, shape, charge distribution, polarity, hydrogen bonding, and hydrophobic interactions of both the ligand (drug) and the receptor (target site). 27
  • Docking also aids in understanding the various enzymes and their mechanisms of actions. 27
  • Molecular docking aids in determining the target sites of the ligand and receptor molecules. 27
  • Not everything can be proven experimentally because standard drug discovery approaches are time consuming. Molecular docking accelerates the process of computer aided drug creation while also providing every conceivable conformation depending on the receptor and ligand molecules. 27
  • The scoring element in docking aids in picking the best match or medicine from a list of possibilities. 27
  • Regarding the investigation of protein interactions, docking offers a significant benefit. 27
  • Millions of substances, ligands, medication, and receptors have solidified three-dimensional structures. These chemicals can be screened virtually. 27

DISADVANTAGES

  • There may be issues with the receptor conformation when protein small molecule docking occurs. Most crystallographic structures have a resolution of 1.5 to 2.5 Angstrom. 27
  • The role of covalently bound inhibitors or ions is virtually always ignored by the scoring methods employed in docking. 27
  • Protein-protein docking research and methods need to be expanded significantly because false positive and false negatives significantly hinder the field’s progress. 27
  • Models are used in molecular docking to forecast how ligands and proteins will interact. The assumptions that underlie these models on the protein-ligand interaction might not always be correct. Molecular docking predictions may become less accurate as a result. 28
  • Protein-ligand interaction kinetics can have a substantial impact on binding affinity, however molecular docking does not take this into consideration. Because of the dynamic nature of protein-ligand interactions, molecular docking predictions may not always be as accurate. 28
  • Molecular docking is a computationally demanding process that demands a large amount of computer power. This may raise the cost of carrying out molecular docking studies and restrict the speed at which predictions can be made. 28

CONCLUSION

Docking study can include the preferred orientation of a molecule when bound to another molecule. This information can be used to predict the strength of the association between the two molecules.

REFRENCES

  1. LaPelusa A, Kaushik R. Physiology, Proteins. [Updated 2022 Nov 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
  2. Watford M, Wu G. Protein. Adv Nutr. 2018 Sep 1;9(5):651-653. doi: 10.1093/advances/nmy027. PMID: 30060014; PMCID: PMC6140426
  3. Haas KL, Franz KJ. Application of metal coordination chemistry to explore and manipulate cell biology. Chem Rev. 2009 Oct;109(10):4921-60. doi: 10.1021/cr900134a. PMID: 19715312; PMCID: PMC2761982
  4. Pizarro AM, Sadler PJ. Unusual DNA binding modes for metal anticancer complexes. Biochimie. 2009 Oct;91(10):1198-211. doi: 10.1016/j.biochi.2009.03.017. Epub 2009 Apr 1. PMID: 19344743; PMCID: PMC2923023.
  5. Pinzi L, Rastelli G. Molecular Docking: Shifting Paradigms in Drug Discovery. Int J Mol Sci. 2019 Sep 4;20(18):4331. doi: 10.3390/ijms20184331. PMID: 31487867; PMCID: PMC6769923.
  6. Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015 Jul 22;20(7):13384-421. doi: 10.3390/molecules200713384. PMID: 26205061; PMCID: PMC6332083.
  7. Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, Ugwuja EI, Aja PM. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. 2023 Aug 17;13(1):13398. doi: 10.1038/s41598-023-40160-2. PMID: 37592012; PMCID: PMC10435576.
  8. Guedes IA, de Magalhães CS, Dardenne LE. Receptor-ligand molecular docking. Biophys Rev. 2014 Mar;6(1):75-87. doi: 10.1007/s12551-013-0130-2. Epub 2013 Dec 21. PMID: 28509958; PMCID: PMC5425711.
  9. Torres PHM, Sodero ACR, Jofily P, Silva-Jr FP. Key Topics in Molecular Docking for Drug Design. Int J Mol Sci. 2019 Sep 15;20(18):4574. doi: 10.3390/ijms20184574. PMID: 31540192; PMCID: PMC6769580.
  10. Mohanty M, Mohanty PS. Molecular docking in organic, inorganic, and hybrid systems: a tutorial review. Monatsh Chem. 2023 Jun 6:1-25. doi: 10.1007/s00706-023-03076-1. Epub ahead of print. PMID: 37361694; PMCID: PMC10243279.
  11. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602. PMID: 21534921; PMCID: PMC3151162.
  12. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602. PMID: 21534921; PMCID: PMC3151162.
  13. Clark KP, Ajay, Flexible ligand docking without parameter adjustment across four ligand-receptor complexes. J Comput Chem. 1995;16:1210-1226.
  14. Keseru GM, Makara GM. Hit discovery and hit-to-lead approaches. Drug Discov Today. 2006 Aug;11(15-16):741-8. doi: 10.1016/j.drudis.2006.06.016. PMID: 16846802.
  15. Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson AJ. Virtual Screening with AutoDock: Theory and Practice. Expert Opin Drug Discov. 2010 Jun 1;5(6):597-607. doi: 10.1517/17460441.2010.484460. PMID: 21532931; PMCID: PMC3083070.
  16. Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol. 2011 Mar;162(6):1239-49. doi: 10.1111/j.1476-5381.2010.01127.x. PMID: 21091654; PMCID: PMC3058157.
  17. Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016 May;11(5):905-19. doi: 10.1038/nprot.2016.051. Epub 2016 Apr 14. PMID: 27077332; PMCID: PMC4868550.
  18. Grassmann G, Miotto M, Desantis F, Di Rienzo L, Tartaglia GG, Pastore A, Ruocco G, Monti M, Milanetti E. Computational Approaches to Predict Protein-Protein Interactions in Crowded Cellular Environments. Chem Rev. 2024 Apr 10;124(7):3932-3977. doi: 10.1021/acs.chemrev.3c00550. Epub 2024 Mar 27. PMID: 38535831; PMCID: PMC11009965.
  19. Huang W, Nussinov R, Zhang J. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design. Methods Mol Biol. 2017;1529:439-446. doi: 10.1007/978-1-4939-6637-0_23. PMID: 27914066; PMCID: PMC7920515.
  20. Cooper GM. The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer Associates; 2000. Expression of Genetic Information.
  21. Sliwoski G, Kothiwale S, Meiler J, Lowe EW Jr. Computational methods in drug discovery. Pharmacol Rev. 2013 Dec 31;66(1):334-95. doi: 10.1124/pr.112.007336. PMID: 24381236; PMCID: PMC3880464.
  22. Engqvist MKM, Rabe KS. Applications of Protein Engineering and Directed Evolution in Plant Research. Plant Physiol. 2019 Mar;179(3):907-917. doi: 10.1104/pp.18.01534. Epub 2019 Jan 9. PMID: 30626612; PMCID: PMC6393796.
  23. Ndochinwa OG, Wang QY, Amadi OC, Nwagu TN, Nnamchi CI, Okeke ES, Moneke AN. Current status and emerging frontiers in enzyme engineering: An industrial perspective. Heliyon. 2024 Jun 7;10(11):e32673. doi: 10.1016/j.heliyon.2024.e32673. PMID: 38912509; PMCID: PMC11193041.
  24. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602. PMID: 21534921; PMCID: PMC3151162.
  25. Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, Ugwuja EI, Aja PM. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. 2023 Aug 17;13(1):13398. doi: 10.1038/s41598-023-40160-2. PMID: 37592012; PMCID: PMC10435576.
  26. Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016 May;11(5):905-19. doi: 10.1038/nprot.2016.051. Epub 2016 Apr 14. PMID: 27077332; PMCID: PMC4868550.
  27. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602. PMID: 21534921; PMCID: PMC3151162.
  28. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602. PMID: 21534921; PMCID: PMC3151162.

Reference

  1. LaPelusa A, Kaushik R. Physiology, Proteins. [Updated 2022 Nov 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
  2. Watford M, Wu G. Protein. Adv Nutr. 2018 Sep 1;9(5):651-653. doi: 10.1093/advances/nmy027. PMID: 30060014; PMCID: PMC6140426
  3. Haas KL, Franz KJ. Application of metal coordination chemistry to explore and manipulate cell biology. Chem Rev. 2009 Oct;109(10):4921-60. doi: 10.1021/cr900134a. PMID: 19715312; PMCID: PMC2761982
  4. Pizarro AM, Sadler PJ. Unusual DNA binding modes for metal anticancer complexes. Biochimie. 2009 Oct;91(10):1198-211. doi: 10.1016/j.biochi.2009.03.017. Epub 2009 Apr 1. PMID: 19344743; PMCID: PMC2923023.
  5. Pinzi L, Rastelli G. Molecular Docking: Shifting Paradigms in Drug Discovery. Int J Mol Sci. 2019 Sep 4;20(18):4331. doi: 10.3390/ijms20184331. PMID: 31487867; PMCID: PMC6769923.
  6. Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015 Jul 22;20(7):13384-421. doi: 10.3390/molecules200713384. PMID: 26205061; PMCID: PMC6332083.
  7. Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, Ugwuja EI, Aja PM. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. 2023 Aug 17;13(1):13398. doi: 10.1038/s41598-023-40160-2. PMID: 37592012; PMCID: PMC10435576.
  8. Guedes IA, de Magalhães CS, Dardenne LE. Receptor-ligand molecular docking. Biophys Rev. 2014 Mar;6(1):75-87. doi: 10.1007/s12551-013-0130-2. Epub 2013 Dec 21. PMID: 28509958; PMCID: PMC5425711.
  9. Torres PHM, Sodero ACR, Jofily P, Silva-Jr FP. Key Topics in Molecular Docking for Drug Design. Int J Mol Sci. 2019 Sep 15;20(18):4574. doi: 10.3390/ijms20184574. PMID: 31540192; PMCID: PMC6769580.
  10. Mohanty M, Mohanty PS. Molecular docking in organic, inorganic, and hybrid systems: a tutorial review. Monatsh Chem. 2023 Jun 6:1-25. doi: 10.1007/s00706-023-03076-1. Epub ahead of print. PMID: 37361694; PMCID: PMC10243279.
  11. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602. PMID: 21534921; PMCID: PMC3151162.
  12. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602. PMID: 21534921; PMCID: PMC3151162.
  13. Clark KP, Ajay, Flexible ligand docking without parameter adjustment across four ligand-receptor complexes. J Comput Chem. 1995;16:1210-1226.
  14. Keseru GM, Makara GM. Hit discovery and hit-to-lead approaches. Drug Discov Today. 2006 Aug;11(15-16):741-8. doi: 10.1016/j.drudis.2006.06.016. PMID: 16846802.
  15. Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson AJ. Virtual Screening with AutoDock: Theory and Practice. Expert Opin Drug Discov. 2010 Jun 1;5(6):597-607. doi: 10.1517/17460441.2010.484460. PMID: 21532931; PMCID: PMC3083070.
  16. Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol. 2011 Mar;162(6):1239-49. doi: 10.1111/j.1476-5381.2010.01127.x. PMID: 21091654; PMCID: PMC3058157.
  17. Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016 May;11(5):905-19. doi: 10.1038/nprot.2016.051. Epub 2016 Apr 14. PMID: 27077332; PMCID: PMC4868550.
  18. Grassmann G, Miotto M, Desantis F, Di Rienzo L, Tartaglia GG, Pastore A, Ruocco G, Monti M, Milanetti E. Computational Approaches to Predict Protein-Protein Interactions in Crowded Cellular Environments. Chem Rev. 2024 Apr 10;124(7):3932-3977. doi: 10.1021/acs.chemrev.3c00550. Epub 2024 Mar 27. PMID: 38535831; PMCID: PMC11009965.
  19. Huang W, Nussinov R, Zhang J. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design. Methods Mol Biol. 2017;1529:439-446. doi: 10.1007/978-1-4939-6637-0_23. PMID: 27914066; PMCID: PMC7920515.
  20. Cooper GM. The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer Associates; 2000. Expression of Genetic Information.
  21. Sliwoski G, Kothiwale S, Meiler J, Lowe EW Jr. Computational methods in drug discovery. Pharmacol Rev. 2013 Dec 31;66(1):334-95. doi: 10.1124/pr.112.007336. PMID: 24381236; PMCID: PMC3880464.
  22. Engqvist MKM, Rabe KS. Applications of Protein Engineering and Directed Evolution in Plant Research. Plant Physiol. 2019 Mar;179(3):907-917. doi: 10.1104/pp.18.01534. Epub 2019 Jan 9. PMID: 30626612; PMCID: PMC6393796.
  23. Ndochinwa OG, Wang QY, Amadi OC, Nwagu TN, Nnamchi CI, Okeke ES, Moneke AN. Current status and emerging frontiers in enzyme engineering: An industrial perspective. Heliyon. 2024 Jun 7;10(11):e32673. doi: 10.1016/j.heliyon.2024.e32673. PMID: 38912509; PMCID: PMC11193041.
  24. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602. PMID: 21534921; PMCID: PMC3151162.
  25. Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, Ugwuja EI, Aja PM. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. 2023 Aug 17;13(1):13398. doi: 10.1038/s41598-023-40160-2. PMID: 37592012; PMCID: PMC10435576.
  26. Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016 May;11(5):905-19. doi: 10.1038/nprot.2016.051. Epub 2016 Apr 14. PMID: 27077332; PMCID: PMC4868550.
  27. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602. PMID: 21534921; PMCID: PMC3151162.
  28. Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57. doi: 10.2174/157340911795677602. PMID: 21534921; PMCID: PMC3151162.

Photo
Deepak Venkataraman N.
Corresponding author

GRT Institute of Pharmaceutical Education and Research, Thirutani

Photo
Bharathwaj J.
Co-author

GRT Institute of Pharmaceutical Education and Research, Thirutani

Photo
Charumathi P.
Co-author

GRT Institute of Pharmaceutical Education and Research, Thirutani

Photo
Lakshminarasimman S.
Co-author

GRT Institute of Pharmaceutical Education and Research, Thirutani

Photo
Purushothaman V. M.
Co-author

GRT Institute of Pharmaceutical Education and Research, Thirutani

Photo
Sudharsan S.
Co-author

GRT Institute of Pharmaceutical Education and Research, Thirutani

Bharathwaj J., Deepak Venkataraman N.*, Charumathi P., Lakshminarasimman S., Purushothaman V. M., Sudharsan S., An Overview of Basics, Types, Approaches, Applications, Advantages and Disadvantages of Docking, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 3, 437-445. https://doi.org/10.5281/zenodo.14992121

More related articles
Benzothiophene: Assorted Bioactive Effects...
Sreeja S. , Vani V. , Akshay Kumar A. , B. Gopika, Devatharun V. ...
Analyzing potential phyto-constituents from Acalyp...
Namrata Waghmare , Poonam Charde , Pooja Mahajan , Kavita Mate, P...
Insilico Drug Design and Molecular Docking Studies of Some Novel Quinozoline Der...
Priyadharshini R., Neelambari S., Jawaharsamuvel R., Mohammed Idrees H., ...
Drug Interaction Study of Gastric Irritant Drugs (Nsaids, Iron Supplements and A...
Deepak Venkataraman N., Charumathi P., Bharathwaj J., Lakshminarasimman S., Purushothaman K., Sudhar...
The Study of Insilco Design and Biological Evaluation of Naphthalene Derivatives...
Akshara Vinayakrishnan , Malavika K., Aneesha Thomas , Aswagosh K., ...
Related Articles
Design, Docking and ADME-T Prediction of Novel Pyrimidine-Based Antimicrobials v...
Shubham Khandare , Dinesh Kawade, Dhananjay Tidke, Nikita Gaikwad, Ritik Jamgade, ...
In Silico Design And ADME Study Of Novel Benzimidazole Containing Derivatives As...
Sandip S. Chaudhari , Megha R. Mahajan , Puja R. Khodape, Diksha N. Koli, Tarannum R. Sayyyad , Pras...
Drug Design: A Comprehensive Review...
Aditee Kagde , Dr. Mrunal Shirsat , Anjali Zende , ...
Benzothiophene: Assorted Bioactive Effects...
Sreeja S. , Vani V. , Akshay Kumar A. , B. Gopika, Devatharun V. R. , Fevin John, Thrisha Cherian, ...
More related articles
Benzothiophene: Assorted Bioactive Effects...
Sreeja S. , Vani V. , Akshay Kumar A. , B. Gopika, Devatharun V. R. , Fevin John, Thrisha Cherian, ...
Analyzing potential phyto-constituents from Acalypha indica Linn (Haritamanjari)...
Namrata Waghmare , Poonam Charde , Pooja Mahajan , Kavita Mate, Poonam Pise, ...
Benzothiophene: Assorted Bioactive Effects...
Sreeja S. , Vani V. , Akshay Kumar A. , B. Gopika, Devatharun V. R. , Fevin John, Thrisha Cherian, ...
Analyzing potential phyto-constituents from Acalypha indica Linn (Haritamanjari)...
Namrata Waghmare , Poonam Charde , Pooja Mahajan , Kavita Mate, Poonam Pise, ...